Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001193125-23-216622
Filing Date
2023-08-21
Accepted
2023-08-21 08:22:25
Documents
1
Effectiveness Date
2023-08-21

Document Format Files

Seq Description Document Type Size
1 15-12G d531495d1512g.htm 15-12G 10187
  Complete submission text file 0001193125-23-216622.txt   11200
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Filer) CIK: 0001821323 (see all company filings)

EIN.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-39746 | Film No.: 231187393
SIC: 2834 Pharmaceutical Preparations